BIOCRYST PHARMACEUTICALS INC (BCRX) › Cash & EquivalentsBIOCRYST PHARMACEUTICALS INC (BCRX) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2008-12-31: $22.34M2009-12-31: $41.12M2010-12-31: $13.62M2011-12-31: $16.44M2012-12-31: $20.89M2013-12-31: $21.16M2014-12-31: $54.54M2015-12-31: $28.90M2016-12-31: $22.10M2017-12-31: $50.28M2018-12-31: $26.73M2019-12-31: $114.17M2020-12-31: $272.13M2021-12-31: $504.39M2022-12-31: $304.77M2023-12-31: $110.64M2024-12-31: $104.71M2025-12-31: $89.74M$89.74M2008-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$89.74M-14.3%2026-02-26Balance as of period end2024-12-31$104.71M-5.4%2026-02-26Balance as of period end2023-12-31$110.64M-63.7%2026-02-26Balance as of period end2022-12-31$304.77M-39.6%2025-02-25Balance as of period end2021-12-31$504.39M+85.4%2023-02-27Balance as of period end2020-12-31$272.13M+138.3%2022-02-28Balance as of period end2019-12-31$114.17M+327.1%2021-03-01Balance as of period end2018-12-31$26.73M-46.8%2020-03-13Balance as of period end2017-12-31$50.28M+127.5%2019-03-14Balance as of period end2016-12-31$22.10M-23.5%2018-03-12Balance as of period end2015-12-31$28.90M-47.0%2018-03-12Balance as of period end2014-12-31$54.54M+157.7%2018-03-12Balance as of period end2013-12-31$21.16M+1.3%2017-02-27Balance as of period end2012-12-31$20.89M+27.0%2016-02-26Balance as of period end2011-12-31$16.44M+20.7%2015-03-02Balance as of period end2010-12-31$13.62M-66.9%2014-03-10Balance as of period end2009-12-31$41.12M+84.1%2013-03-11Balance as of period end2008-12-31$22.34M—2012-03-06Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)